Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Iridex TruFocus LIO Premiere" Laser Indirect Ophthalmoscope ( LIO ) Recalled by Iridex Corporation Due to It was discovered that the laser energy was...

Date: February 27, 2018
Company: Iridex Corporation
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Iridex Corporation directly.

Affected Products

Iridex TruFocus LIO Premiere" Laser Indirect Ophthalmoscope ( LIO ) The LIO is a headmounted indirect ophthalmoscope which is used with a handheld lens to view and perform laser treatments on a patient s retina. It allows binocular visualization of the peripheral retina and can be used to evaluate and treat patients.

Quantity: US - 58 OUS - 46

Why Was This Recalled?

It was discovered that the laser energy was not going where intended to put it, resulting in focal cataracts and iris burns.

Where Was This Sold?

Worldwide Distribution - USA Distribution and to the countries of : China, Germany, Australia, Canada, Ireland, Lebanon, Japan, Israel and Qatar

About Iridex Corporation

Iridex Corporation has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report